Chapter 07: Oncology - Dr. Sanjoy Ray

Systemic anti-cancer therapy (SACT)
Systemic anti-cancer therapy (SACT)
0
Date
16 Jan, 2025
Systemic anti-cancer therapy (SACT) Cytotoxic chemotherapy They work by interfering with the processes involved in cell division. Side […]
Read more
Malignant pleural effusion
Malignant pleural effusion
0
Date
16 Jan, 2025
Malignant pleural effusion About 40% of all pleural effusions are due to malignancy. Presence of an effusion indicates incurable […]
Read more
Tumor lysis syndrome
Tumor lysis syndrome
0
Date
16 Jan, 2025
Tumor lysis syndrome Definition: group of metabolic abnormalities occurring as a complication of treatment of cancer, caused by destruction […]
Read more
Immune-related adverse events (IRAE)
Immune-related adverse events (IRAE)
0
Date
16 Jan, 2025
Immune-related adverse events (IRAE) Checkpoint inhibitor immunotherapy is now widely used in the treatment of many different cancers. Side-effects […]
Read more
Hypercalcemia in malignancy
Hypercalcemia in malignancy
0
Date
16 Jan, 2025
Hypercalcemia in malignancy Causes: PTHrP Direct bone metastasis Ectopic PTH secretion Investigation: S calcium with albumin Medical […]
Read more
Neutropenic fever
Neutropenic fever
0
Date
16 Jan, 2025
Neutropenic fever Fever in patient on chemotherapy: infection tumor necrosis drug reaction transfusion reaction Neutropenic fever (& sepsis) (SAQ, […]
Read more
CUP / MUO
CUP / MUO
0
Date
16 Jan, 2025
CUP / MUO Definition: Where the primary site remains unclear following comprehensive investigations, a patient is said to have […]
Read more
Investigation in cancer patient
Investigation in cancer patient
0
Date
16 Jan, 2025
Investigation are done to see the extent of disease type of cancer patient’s fitness. To See the Type of […]
Read more
Breaking Bad News
Breaking Bad News
0
Date
16 Jan, 2025
Breaking Bad News The SPIKES protocol for breaking bad news Four objectives: Gathering information from the patient Transmitting […]
Read more